| 188th ENMC international workshop: inclusion body myositis, 2–4 December 2011, Naarden, The Netherlands MR Rose, enMC iBM Working Group Neuromuscular Disorders 23 (12), 1044-1055, 2013 | 336 | 2013 |
| Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis H Pluk, BJA Van Hoeve, SHJ Van Dooren, J Stammen‐Vogelzangs, ... Annals of neurology 73 (3), 397-407, 2013 | 261 | 2013 |
| Epidemiology of inclusion body myositis in the Netherlands: a nationwide study UA Badrising, M Maat-Schieman, SG Van Duinen, F Breedveld, ... Neurology 55 (9), 1385-1388, 2000 | 242 | 2000 |
| A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities FM Cox, MJ Titulaer, JK Sont, AR Wintzen, JJGM Verschuuren, ... Brain 134 (11), 3167-3175, 2011 | 201 | 2011 |
| Inclusion body myositis: clinical features and clinical course of the disease in 64 patients UA Badrising, MLC Maat-Schieman, JC van Houwelingen, PA van Doorn, ... Journal of neurology 252, 1448-1454, 2005 | 159 | 2005 |
| Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases MK Herbert, J Stammen-Vogelzangs, MM Verbeek, A Rietveld, ... Annals of the rheumatic diseases 75 (4), 696-701, 2016 | 150 | 2016 |
| Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis FM Cox, M Reijnierse, CSP van Rijswijk, AR Wintzen, JJ Verschuuren, ... Rheumatology 50 (6), 1153-1161, 2011 | 149 | 2011 |
| Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo UA Badrising, MLC Maat‐Schieman, MD Ferrari, AH Zwinderman, ... Annals of Neurology: Official Journal of the American Neurological …, 2002 | 139 | 2002 |
| Detecting dysphagia in inclusion body myositis FM Cox, JJ Verschuuren, BM Verbist, EH Niks, AR Wintzen, UA Badrising Journal of neurology 256, 2009-2013, 2009 | 123 | 2009 |
| International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 122 | 2017 |
| Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis UA Badrising, GMT Schreuder, MJ Giphart, K Geleijns, J Verschuuren, ... Neurology 63 (12), 2396-2398, 2004 | 120 | 2004 |
| Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial MG Hanna, UA Badrising, O Benveniste, TE Lloyd, M Needham, H Chinoy, ... The Lancet Neurology 18 (9), 834-844, 2019 | 119 | 2019 |
| Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis JB Lilleker, A Rietveld, SR Pye, K Mariampillai, O Benveniste, ... Annals of the rheumatic diseases 76 (5), 862-868, 2017 | 92 | 2017 |
| Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy J Lim, A Rietveld, JL De Bleecker, UA Badrising, CGJ Saris, ... Neurology: Neuroimmunology & Neuroinflammation 6 (1), e513, 2018 | 69 | 2018 |
| Dysphagia in ambulant patients with Parkinson's disease: common, not dangerous AR Wintzen, UA Badrising, RAC Roos, J Vielvoye, L Liauw, EKJ Pauwels Canadian journal of neurological sciences 21 (1), 53-56, 1994 | 66 | 1994 |
| Inclusion body myositis JJ Verschuuren, UA Badrising, BG Van Engelen, JH Van der Hoeven, ... Diagnostic criteria for neuromuscular disorders 2, 81-84, 1997 | 65 | 1997 |
| Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial C Walgaard, BC Jacobs, HF Lingsma, EW Steyerberg, B van den Berg, ... The Lancet Neurology 20 (4), 275-283, 2021 | 57 | 2021 |
| Second IVIg Course in Guillain‐Barré Syndrome patients with poor prognosis (SID‐GBS trial): protocol for a double‐blind randomized, placebo‐controlled clinical trial C Walgaard, BC Jacobs, HF Lingsma, EW Steyerberg, DR Cornblath, ... Journal of the Peripheral Nervous System 23 (4), 210-215, 2018 | 57 | 2018 |
| Interventions for dysphagia in long‐term, progressive muscle disease K Jones, RDS Pitceathly, MR Rose, S McGowan, M Hill, UA Badrising, ... The Cochrane database of systematic reviews 2016 (2), 2016 | 57 | 2016 |
| The heart in sporadic inclusion body myositis: a study in 51 patients FM Cox, V Delgado, JJ Verschuuren, BE Ballieux, JJ Bax, AR Wintzen, ... Journal of neurology 257, 447-451, 2010 | 53 | 2010 |
